Immunology and Microbiology
T Cell
100%
Cytotoxic T-Cell
64%
Immune Checkpoint Blockade
37%
Mouse
36%
COVID-19
32%
Influenza
32%
Adoptive Immunity
32%
Neoantigen
32%
Agonist
32%
Intravenous Immunoglobulin
32%
Phenotype
32%
TLR9
32%
CD44v Antigen
32%
Lifespan
32%
Experimental Autoimmune Encephalomyelitis
32%
Vaccine Efficacy
25%
Cytokine Production
16%
Cytokine
16%
CD44
16%
Multiple Sclerosis
16%
Immune Response
12%
RNA Sequencing
10%
Transcription Factors
10%
down Regulation
9%
Viral Disease
9%
Influenza Virus
9%
Wild Type
8%
Severe Acute Respiratory Syndrome Coronavirus 2
8%
Dendritic Cell
6%
TLR3
6%
C57BL 6 Mouse
6%
Cell Activation
6%
Polyinosinic:polycytidylic Acid
6%
CpG Oligodeoxynucleotide
6%
Pattern Recognition Receptor
6%
Vaccination Policy
6%
Immunotherapy
6%
Peptide Vaccine
6%
Immunostimulation
5%
Cancer Immunotherapy
5%
Upregulation
5%
Medicine and Dentistry
Cytotoxic T-Cell
50%
T Cell
44%
Immune Checkpoint Blockade
35%
Solid Malignant Neoplasm
32%
Phosphotransferase
32%
Ibrutinib
32%
Cytokine Production
13%
Immunostimulation
12%
In Vitro
10%
Transcription Factors
10%
Phosphotransferase Inhibitor
9%
Receptor Expression
7%
RNA Sequencing
5%
Pharmacology, Toxicology and Pharmaceutical Science
CD8 Antigen
64%
Solid Malignant Neoplasm
32%
Phosphotransferase
32%
Ibrutinib
32%
Cytokine
16%
Phosphotransferase Inhibitor
16%
Malignant Neoplasm
13%
Transcription Factors
13%
Receptor
11%
Immunotherapy
11%
Mesothelioma
8%
Pancreas Cancer
8%
T Lymphocyte Receptor
8%
Melanoma
8%
Mouse
5%
